Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Galinpepimut-S
Trade Name
Synonyms SLS-001|SLS001|SLS 001
Drug Descriptions

Galinpepimut-S (SLS-001) is a WT1 vaccine comprised of four WT1 peptides, which may result in a CD4 and CD8 T cell immune response against WT1-expressing tumor cells (PMID: 28972039, PMID: 29386195).

CAS Registry Number NA
NCIT ID C161778


  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"


  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Galinpepimut-S Galinpepimut-S 0 2
Galinpepimut-S + Nivolumab + Sargramostim Galinpepimut-S Nivolumab Sargramostim 0 1
Galinpepimut-S + Pembrolizumab Galinpepimut-S Pembrolizumab 0 1

Additional content available in CKB BOOST